Phase II Study of Amrubicin Monotherapy in Elderly or Poor-Risk Patients with Extensive Disease of Small Cell Lung Cancer

被引：0
|
作者：
Igawa, S. [1 ]
Fukui, T. [1 ]
Shirasawa, M. [1 ]
Ozawa, T. [1 ]
Sone, H. [1 ]
Kusuhara, S. [1 ]
Nishinarita, N. [1 ]
Hiyoshi, Y. [1 ]
Kubota, M. [1 ]
Mitsufuji, H. [2 ]
Sasaki, J. [3 ]
Katagiri, M. [4 ]
Naoki, K. [1 ]
机构：
[1] Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan
[2] Kitasato Univ, Sch Nursing, Sagamihara, Kanagawa, Japan
[3] Kitasato Univ, Sch Med, Res & Dev Ctr New Med Frontiers, Sagamihara, Kanagawa, Japan
[4] Kitasato Univ, Sch Allied Hlth Sci, Sagamihara, Kanagawa, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Small Cell Lung Cancer; Elderly patients; Performance status; Amrubicin;
D O I：
10.1016/j.jtho.2018.08.837
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.12-02
引用
收藏
页码：S573 / S573
页数：1
相关论文
共 50 条
  • [41] Clinical impact of amrubicin monotherapy in patients with relapsed small cell lung cancer: a multicenter retrospective study
    Uda, Sayaka
    Yamada, Tadaaki
    Yoshimura, Akihiro
    Goto, Yasuhiro
    Yoshimine, Kohei
    Nakamura, Yoichi
    Shiotsu, Shinsuke
    Yokoi, Takashi
    Tamiya, Nobuyo
    Kimura, Hideharu
    Chihara, Yusuke
    Umeda, Yukihiro
    Izumi, Miiru
    Takeda, Takayuki
    Yamada, Takahiro
    Hibino, Makoto
    Hiranuma, Osamu
    Ito, Kazuhiro
    Okada, Asuka
    Osugi, Shuji
    Takemura, Yoshizumi
    Ishii, Hiroshi
    Chibana, Kenji
    Hasegawa, Isao
    Morimoto, Yoshie
    Iwasaku, Masahiro
    Tokuda, Shinsaku
    Takayama, Koichi
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, : 1847 - 1857
  • [42] Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702
    Okamoto, H.
    Watanabe, K.
    Kunikane, H.
    Yokoyama, A.
    Kudoh, S.
    Asakawa, T.
    Shibata, T.
    Kunitoh, H.
    Tamura, T.
    Saijo, N.
    BRITISH JOURNAL OF CANCER, 2007, 97 (02) : 162 - 169
  • [43] Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702
    H Okamoto
    K Watanabe
    H Kunikane
    A Yokoyama
    S Kudoh
    T Asakawa
    T Shibata
    H Kunitoh
    T Tamura
    N Saijo
    British Journal of Cancer, 2007, 97 : 162 - 169
  • [44] PHASE II STUDY OF WEEKLY AMRUBICIN IN PATIENTS WITH REFRACTORY OR RELAPSED NON-SMALL CELL LUNG CANCER
    Iwasaku, Masahiro
    Nishiyama, Akihiro
    Watanabe, Naoki
    Kunimasa, Kei
    Tsubouchi, Kazuya
    Oka, Saori
    Yoshioka, Hiroshige
    Kitagawa, Chiyoe
    Saka, Hideo
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S875 - S875
  • [45] PHASE II STUDY OF IRINOTECAN PLUS CISPLATIN FOLLOWED BY AMRUBICIN IN PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL LUNG CANCER (WJTOG 0301)
    Iwamoto, Y.
    Kobayashi, M.
    Matsui, K.
    Yamamoto, H.
    Yamazaki, K.
    Saka, H.
    Sawa, T.
    Shibata, K.
    Takeda, K.
    Nakagawa, K.
    ANNALS OF ONCOLOGY, 2008, 19 : 117 - 117
  • [46] PHASE II STUDY OF AMRUBICIN (AMR) COMBINED WITH CARBOPLATIN (CBDCA) FOR ELDERLY PATIENTS WITH SMALL CELL LUNG CANCER (SCLC). (NORTH JAPAN LUNG CANCER GROUP 0405)
    Nakamura, A.
    Sugawara, S.
    Harada, M.
    Usui, K.
    Suzuki, T.
    Yokouchi, H.
    Maemondo, M.
    Nukiwa, T.
    Inoue, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 117 - 118
  • [47] Phase II study of irinotecan plus cisplatin followed by amrubicin in patients with extensive-stage small-cell lung cancer (WJTOG 0301)
    Iwamoto, Y.
    Kobayashi, M.
    Matsui, K.
    Yamamoto, H.
    Yamazaki, K.
    Saka, H.
    Sawa, T.
    Shibata, K.
    Takeda, K.
    Nakagawa, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [48] Phase II trial of amrubicin in patients with previously treated small cell lung cancer (SCLC).
    Kato, T.
    Nokihara, H.
    Ohe, Y.
    Yamamoto, N.
    Sekine, I.
    Kunitoh, H.
    Kubota, K.
    Nishiwaki, Y.
    Saijo, N.
    Tamura, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 379S - 379S
  • [49] Phase II study of nedaplatin and irinotecan in patients with extensive small-cell lung cancer
    Fumihiro Oshita
    Makiko Sugiura
    Shuji Murakami
    Tetsuro Kondo
    Haruhiro Saito
    Kouzo Yamada
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 345 - 350
  • [50] Phase II study of nedaplatin and irinotecan in patients with extensive small-cell lung cancer
    Oshita, Fumihiro
    Sugiura, Makiko
    Murakami, Shuji
    Kondo, Tetsuro
    Saito, Haruhiro
    Yamada, Kouzo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (02) : 345 - 350
12345